Qiaoli Wang

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort

Baorui Liu, Yahui Zhu, W. Kong, 2022, Human vaccines & immunotherapeutics.

Concurrent TP53 mutation adversely impact the efficacy of crizotinib in ROS1-rearranged lung cancer patients.

Jun Zhao, X. Ai, F. Yu, 2019, Journal of Clinical Oncology.

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer

Baorui Liu, X. Qian, F. Meng, 2023, Human vaccines & immunotherapeutics.

Characterization of a Norovirus‐specific monoclonal antibody that exhibits wide spectrum binding activities

S. Shen, Jinjin Liu, Yuqi Huo, 2018, Journal of medical virology.